Filer Snapshot

Vivo Capital, LLC

CIK 0001674712. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity type

Company

Total filings

45

Latest filing

20 May 2026

Industry

n/a

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: 13F-HR/A for Q1 2026. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Largest parsed holding

ERAS

$196.61M reported value

Open holding

13D/G large stake

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Source: SEC Form 13F

13F-HR/A filed on 20 May 2026 for CIK 0001674712.

View Source Filing
SEC ownership signals 1 fact
SEC ownership summary

Parsed filing values

Bars compare filing families separately; they should not be added together as one total.

Latest 13F portfolio$1.2B

Quarterly institutional portfolio holdings.

Latest 13F portfolio value

$1.2B

Market value reported in the latest parsed Form 13F portfolio.

Leading 13F symbols

ERAS, PRAX, TERN, TRVI

Largest visible symbols from the latest parsed Form 13F information table.

13F holdings

Largest symbols from the latest parsed Form 13F information table.

ERAS PRAX TERN TRVI DBVT CMPX TNGX SABS
+12 moreCRVS DRUG SVA DNTH DYN ABVX NERV ACRS ORIC ANRO SNSE AVBP
How to read filing-family values
  • Filing families stay separate: 13F portfolio value, 13D/G large stakes, and Forms 3/4/5 owner positions should not be blended into one total.
  • Use the linked research paths to verify each signal against the original SEC filing.
Filer identity 1 fact
Business address
192 Lytton Avenue, Palo Alto, CA, 94301
SEC record 2 facts
State of incorporation
CA
Fiscal year-end
31 December

Filer intelligence

What SEC filings say about Vivo Capital, LLC

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Quick read

  • Latest parsed 13F shows $1.2B across 46 reported holdings for Q1 2026.
  • Largest parsed 13F holding: ERAS at $196.61M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio 46 rows

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 No rows yet

Officer, director, and 10% owner holdings or transactions.

Open

Top parsed 13F holdings

Visual share of the latest parsed 13F portfolio. Values are reported market value, not a recommendation.

Q1 2026 - 20 May 2026

Top 5 concentration

41%

Share of latest parsed 13F value represented by the visible holdings below.

Top 5 reported value

$492.65M

Compared with $1.2B total 13F value.

Top 5 net change

-$157.45M

Position-value change inside the visible top holdings only.

13F concentration map

A simple visual split of the latest parsed 13F portfolio.

Largest add: ERAS ยท Largest trim: TERN

ERAS PRAX TERN TRVI DBVT Other holdings

ERAS

16.3%

Erasca Inc

$196.61M

PRAX

9.1%

Praxis Precision Medicines

$109.19M

TERN

5.8%

Terns Pharmaceuticals Inc

$70.35M

TRVI

5.1%

Trevi Therapeutics Inc

$60.78M

DBVT

4.6%

DBV Technologies SA

$55.73M

Latest update

What changed recently for Vivo Capital, LLC

New filing available

Latest 13F period: Q1 2026. Open the source-backed page to inspect the fresh filing or facts context.

Update date

20 May 2026

Page type

Filer profile

Latest period

Q1 2026

Institutional portfolio context was refreshed from a 13F filing filed on 20 May 2026.

Benchmark Context

Benchmark context for this company

Vivo Capital, LLC has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest 13F period: Q1 2026. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

SEC filing record

CIK 0001674712 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
45
First seen
16 May 2016
Latest filing
20 May 2026
Entity
Company

Observed form types

13F-HR 13F-HR/A

Latest Filings

Showing the latest 12 of 45 SEC filings for Vivo Capital, LLC.

13F-HR/A

13F-HR/A filing

Filing date
20 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
15 May 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
13 Feb 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Nov 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Aug 2025
Reporting date
30 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
12 May 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
13 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
13 Nov 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
22 Apr 2024
Reporting date
31 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
06 Feb 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR

13F-HR filing

Filing date
08 Nov 2023
Reporting date
30 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .